Home / Resource Library / DURABLE EFFICACY WITH FIXED-DURATION EPCORITAMAB + POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA-R-CHP) FOR 1L DIFFUSE LARGE B-CELL LYMPHOMA (EPCORE NHL-5)

DURABLE EFFICACY WITH FIXED-DURATION EPCORITAMAB + POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA-R-CHP) FOR 1L DIFFUSE LARGE B-CELL LYMPHOMA (EPCORE NHL-5)

EHA 2025

Membership Organisation

Healthcare Professional

Affected by Lymphoma

Researcher or Advocate

DURABLE EFFICACY WITH FIXED-DURATION EPCORITAMAB + POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA-R-CHP) FOR 1L DIFFUSE LARGE B-CELL LYMPHOMA (EPCORE NHL-5)